Newman Dignan & Sheerar, Inc. Azur Rx Bio Pharma, Inc. Transaction History
Newman Dignan & Sheerar, Inc.
- $585 Million
- Q3 2024
About AzurRx BioPharma, Inc.
- Ticker AZRX
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,575,104
- Market Cap $271M